INIS
leukemia viruses
100%
bovine
96%
viruses
93%
humans
78%
genes
60%
host
57%
lymphocytes
34%
patients
33%
leukemia
32%
sheep
31%
in vivo
30%
lymphomas
26%
proteins
26%
abundance
25%
mutations
24%
diseases
22%
dna
21%
apoptosis
21%
blood
20%
rna
18%
adults
18%
strains
18%
data
18%
therapy
15%
pathogenesis
15%
dynamics
14%
length
14%
proliferation
13%
tumors
13%
receptors
13%
histones
13%
populations
13%
homeostasis
13%
promoters
13%
induction
12%
in vitro
12%
kinetics
11%
tissues
11%
chromatin
11%
pcr
11%
esters
10%
control
10%
cytidine
10%
interactions
10%
mutants
9%
inflammation
9%
taxes
8%
clone cells
8%
ham
8%
tsp
8%
Immunology and Microbiology
Human T-Lymphotropic Virus 1
47%
Bovine Leukemia Virus
44%
Provirus
23%
Human T Cell Leukemia Virus
20%
Retrovirus
18%
T Cell
16%
Dynamics
14%
Virus Expression
10%
Clonal Variation
10%
Immune Response
9%
Human Adenovirus C
9%
Vaccination Policy
8%
Bovine
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Viral Disease
7%
Wart Virus
7%
DNA Repair
7%
Muscle Cell
7%
Cell Clone
7%
P53
7%
Adenoviridae
7%
Neurite
7%
Transcription Initiation
7%
Glioblastoma Cell Line
7%
Coronavirinae
7%
Neuroblastoma Cell Line
7%
Viral Replication
5%
Lymphocyte
5%
Keyphrases
Virus Research
7%
Myotonic Dystrophy
7%
CRISPR Interference (CRISPRi)
7%
Interferon Therapy
7%
Zidovudine
7%
Neuroinvasion
7%
WIP1
7%
DNA Fragment Length
7%
Estimating Abundance
7%
Infective Dermatitis
7%
Strongyloidiasis
7%
Wider Determinants
7%
Restriction Factor
7%
TCR Diversity
7%
Clonality
7%
Human T-lymphotropic Virus Type I-associated Myelopathy/tropical Spastic Paraparesis
7%
Cell Dynamics
7%
Unifying Model
7%
Human Viruses
7%
Host Restriction Factors
7%
APOBEC3
7%
Activation Therapy
7%
Neurite
7%
Viral Entry Inhibitors
7%
T Cell Development
7%
Human Adenovirus (HAdV)
7%
Innate Antiviral
7%
APOBEC3B
7%
Antiviral Effectors
7%
MiR-138-5p
7%
DNA Decay
7%
Covalently Closed Circular DNA
7%
Valproic Acid
7%
E7 Oncoprotein
7%
Lymphoma Diagnosis
7%
Cellular Dynamics
7%
Peritoneal Dialysis Effluent
7%
Peritoneal Dialysis Patients
7%
Molecular Biology Research
7%
Abnormal Proliferation
7%
Human T-lymphotropic Virus Type 1-associated Myelopathy/tropical Spastic Paraparesis
7%
Entry Inhibitor
5%